MYRIAD GENETICS INC.

Myriad Genetics to Release Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024

21 Feb 2024 16:05:00 By Nasdaq GlobeNewswire

Myriad Genetics Appoints Dallas Reed, MD, FACOG, FACMG as Principal Medical Advisor of Women’s Health

15 Feb 2024 16:05:00 By Nasdaq GlobeNewswire

Myriad Genetics Completes Acquisition of Precise Tumor, Precise Liquid and Laboratory from Intermountain Precision Genomics

01 Feb 2024 09:25:00 By Nasdaq GlobeNewswire

Myriad Genetics Names George Daneker Jr., MD, as President and Chief Clinical Officer of Oncology

30 Jan 2024 17:00:00 By Nasdaq GlobeNewswire

Myriad Genetics to Acquire Precise Tumor, Precise Liquid and Laboratory from Intermountain Precision Genomics

18 Jan 2024 18:10:00 By Nasdaq GlobeNewswire

Myriad Genetics Applauds New Germline Testing Guideline for Patients with Breast Cancer from ASCO-SSO

09 Jan 2024 16:05:00 By Nasdaq GlobeNewswire

Myriad Genetics to Present at 42nd Annual J.P. Morgan Healthcare Conference

03 Jan 2024 16:05:00 By Nasdaq GlobeNewswire

Myriad Genetics Chief Financial Officer Bryan Riggsbee Retires; Scott Leffler Appointed as Successor; Reiterates Previously Issued Financial Guidance

21 Dec 2023 08:30:00 By Nasdaq GlobeNewswire

Myriad Genetics Establishes Comprehensive Pan-Cancer Research Platform to Advance Patient Care

20 Dec 2023 08:00:00 By Nasdaq GlobeNewswire

Myriad Genetics Celebrates One Million SneakPeek® Results Shared with Expectant Parents

20 Nov 2023 16:05:00 By Nasdaq GlobeNewswire

Myriad Genetics and Personalis Partner to Market Solutions to Pharma Customers

16 Nov 2023 16:05:00 By Nasdaq GlobeNewswire

Myriad Genetics to Participate in Stephens Annual Investment Conference

09 Nov 2023 07:00:00 By Nasdaq GlobeNewswire

Myriad Genetics Announces Pricing of Upsized Offering of Common Stock

08 Nov 2023 21:20:00 By Nasdaq GlobeNewswire

Myriad Genetics Announces Proposed Offering of $100 Million of Shares of Common Stock

08 Nov 2023 16:10:56 By Nasdaq GlobeNewswire

Myriad Genetics Reports Third Quarter 2023 Financial Results; Generates Double-Digit Revenue Growth; Raises 2023 Revenue Guidance and Introduces 2024 Revenue Guidance

06 Nov 2023 16:05:01 By Nasdaq GlobeNewswire

Myriad Genetics Appoints Sam Raha as Chief Operating Officer

01 Nov 2023 09:00:00 By Nasdaq GlobeNewswire

Myriad Genetics to Release Third Quarter Financial Results on November 6, 2023

31 Oct 2023 16:05:00 By Nasdaq GlobeNewswire

QIAGEN and Myriad Genetics partner to advance companion diagnostics development for cancer

26 Oct 2023 08:00:00 By Nasdaq GlobeNewswire

New Myriad Genetics Survey Shows Breast Cancer Risk Factors Are Misunderstood

28 Sep 2023 07:00:00 By Nasdaq GlobeNewswire

Myriad Genetics and Illumina Achieve Milestones in Strategic Partnership to Support Biopharma Clinical Trials

19 Sep 2023 09:00:00 By Nasdaq GlobeNewswire